Recent Finacing
Recent Raise
Precision Therapeutics provides ChemoFx, a 10–15 day ex vivo tumor cell assay that grows biopsy-derived cells, tests multiple chemotherapies accounting for genomic factors, and guides oncologists (breast/ovarian focus).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors